Flu Vaccine

Any information obtained here is not to be construed as medical or legal advice. The decision to vaccinate and how you implement that decision is yours and yours alone.

If you have been helped by the information on these pages, please considering donating some to help with my time to research - click above PayPal link. Thank you!


Influenza Vaccination Of Infants: A Useless Risk By F. Edward Yazbak, MD, FAAP

FLU SHOT EFFECTIVENESS WILDLY OVERESTIMATED

Nothing New About Lack Of Effectiveness Of Influenza Vaccination In Babies By F. Edward Yazbak, MD, FAAP

Flu Vaccine WARNING for pregnant women

Influenza Vaccination During Pregnancy: A Very Bad Idea By F. Edward Yazbak, MD, FAAP

Influenza Vaccination During Pregnancy: A Critical Assessment of the Recommendations of the Advisory Committee on Immunization Practices (ACIP) David M. Ayoub, M.D., F. Edward Yazbak, M.D

Influenza Vaccination During Pregnancy: A Critical Assessment of the Recommendations of the Advisory Committee on Immunization Practices (ACIP) David M. Ayoub, M.D., F. Edward Yazbak, M.D

Calculating U.S. Influenza Deaths By F. Edward Yazbak, MD, FAAP

How Many Americans Really Die Of The Flu Each Year? by Jon Rappoport

Influenza Vaccine: Review of Effectiveness of the U.S. Immunization Program, and Policy ConsiderationsDavid A. Geier, B.A., Paul G. King, Ph.D., Mark R. Geier, M.D., Ph.D.
A number of studies have reported that influenza vaccine (IV) administration has been less than optimally effective in certain subpopulations. This study examines yearly influenza death rate, yearly influenza case rate, and yearly rate of hospitalizations with influenza as the first-listed discharge diagnosis. By these measures, the yearly U.S. mass influenza vaccination campaign has been ineffective in preventing influenza in vaccine recipients. The use of antiviral drugs to treat influenza, in light of the potential for an influenza pandemic, needs further consideration.

Influenza vaccination and Guillain Barre syndrome Mark R. Geier, David A. Geier, and Arthur C. Zahalsky
Acute and severe Guillain Barre Syndrome (GBS) cases reported following influenza vaccine to the Vaccine Adverse Events Reporting System (VAERS) database from 1991 through 1999 were examined. Endotoxin concentrations were measured using the Limulus amebocyte lysate assay in influenza vaccines. There were a total of 382 cases of GBS reported to the VAERS database following influenza vaccination (male/female ratio, 1.2). The median onset of GBS following influenza vaccine was 12 days (interquartile range, 7 days to 21 days). There was an increased risk of acute GBS (relative risk, 4.3; 95% confidence interval, 3.0 to 6.4) and severe GBS (relative risk, 8.5; 95% confidence interval, 3.7 to 18.9) in comparison to an adult tetanus– diphtheria (Td) vaccine control group. There were maximums in the incidence of GBS following influenza vaccine that occurred approximately every third year (1993, 1996, and 1998) and statistically significant variation in the incidence of GBS among different influenza manufacturers. Influenza vaccines contained from a 125- to a 1250-fold increase in endotoxin concentrations in comparison to an adult Td vaccine control and endotoxin concentrations varied up to 10-fold among different lots and manufacturers of influenza vaccine. The biologic mechanism for GBS following influenza vaccine may involve the synergistic effects of endotoxin and vaccine-induced autoimmunity. There were minimal potential reporting biases in the data reported to the VAERS database in this study. Patients should make an informed consent decision on whether to take this optional vaccine based upon its safety and efficacy and physicians should vigilantly report GBS following influenza vaccination to the VAERS in the United States so that continued evaluation of the safety of influenza vaccine may be undertaken.

The Flu Vaccine Crisis: Did we miss a Red Flag? By RDF Columnist, Dr. F. Edward Yazbak, November 2004
If you have difficulty accessing this, email me

A SHOT IN THE DARK - Doctors question CDC flu statistics By KELLY O'MEARA, November 2004

The Flu Season Campaign Begins By Dr. Sherri Tenpenny, October 2004

Annual Number of flu deaths: it’s a guess By Sherri Tenpenny, DO, October 2004

The Flu Scare Game by John Keller, October 2004

HYPING VACCINES: AN INVESTIGATION Chickenpox, Lyme, Rotavirus, And A Highly Revealing Analysis Of Flu Statistics By RFD Columnist, Dr. F. Edward Yazbak, January 2004

IS IT POSSIBLE THAT FluMist®, THE NASAL SPRAY FLU VACCINE, MAY BE CAUSING THE FLU? By RFD Columnist, Dr. Sherri Tenpenny, December 2003

"In addition, only 3% (157) of the H3N2 viruses were indentified as subtypes. This is an extraordinarily small test sample. Even though the A/Fujian strain has been found in 71% (112) of this sample, what is being downplayed is that nearly 30% of the viruses have been identified as “antigenically similar” to viruses found in FluZone and FluMist: 45 samples (29%) had A/Panama strain viruses and 1 sample had the A/New Caladonia virus." "What is of great concern it that the CDC has subtyped so few samples. What if 50% or 60% or 80% had been subtyped? Would more A/Panama and A/New Caladonia viruses have been found? Would further testing implicate FluMist as a source of influenza?"

SHOULD YOU GET THE FLU SHOT? By Dr Sherri Tenpenny, November 2003
EMAIL me if you are not able to access this file vaccineinfo@tesco.net

Risks of FluMist Vaccine An Investigation By Dr. Sherri Tenpenny, October 2003

NVIC - National Vaccine Information Center Press Release -Wednesday, December 10, 2003 - INFORMED CONSENT ADVOCATE SAYS GOVERNMENT AND INDUSTRY SHOULD RELEASE FLU VACCINE EFFECTIVENESS DATA

Flu Vaccine International Vaccination Newsletter

They goofed in figuring out the 1997/1998 flu strains - Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly

Journal of Medical Virology, Volume 61, Issue 1, 2000. Pages: 94-99, Published Online: 31 Mar 2000

We are talking 50% here! - Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine Journal of Medical Virology, Volume 61, Issue 1, 2000. Pages: 100-106, Published Online: 31 Mar 2000

Why A Flu Shortage in 2000??? Wyeth-Ayerst Pays For Violations

Illness after influenza vaccination reported through a nationwide surveillance system, 1976-1977. Am J Epidemiol 1980 Mar;111(3):270-8

Is There A Vaccination Link To Chronic Fatigue Sydrome? Flu Shots & Chronic Fatigue???

Influenza & the vaccine

More links on Flu Vaccine

The Swine Flu Epidemic That NEVER WAS!

Flu Vaccine Adverse Reactions

Flu Vaccines Interview with Dr. Eva Snead on Gary Null, radio program

FDA Halts Production of Fluogen Influenza Virus Vaccine "The FDA notified Parkedale Pharmaceuticals, Inc. that the production of the company's influenza virus vaccine, Fluogen, fails to comply with current good manufacturing practice standards."
you need to register for medscape but it is free.

more info here

More Flu Vaccine Links

Flu - the Disease statistics


Vaccine Bookstore

Highly recommended books


Back to main Vaccine Dangers Page


Please call, write or email for more detailed information wwithin@nccn.net


Please call, write or email for more detailed information vaccinedangers@gmail.com

Back to Top